| Literature DB >> 32407898 |
Alexandre J Vivanti1, Philippe Deruelle2, Olivier Picone3, Sophie Guillaume4, Jean-Christophe Roze5, Blandine Mulin6, Fabienne Kochert7, Isabelle De Beco8, Sophie Mahut8, Adrien Gantois4, Chloé Barasinski9, Karine Petitprez10, Anne-Françoise Pauchet-Traversat10, Alcyone Droy10, Alexandra Benachi11.
Abstract
INTRODUCTION: In the context of the stage 3 SARS-Cov-2 epidemic situation, it is necessary to put forward a method of rapid response for an HAS position statement in order to answer to the requests from the French Ministry of Solidarity and Health, healthcare professionals and/or health system users' associations, concerning post-natal follow-up for women and neonates during the COVID-19 pandemic.Entities:
Mesh:
Year: 2020 PMID: 32407898 PMCID: PMC7212945 DOI: 10.1016/j.jogoh.2020.101805
Source DB: PubMed Journal: J Gynecol Obstet Hum Reprod ISSN: 2468-7847
Post-natal follow-up for women and neonates during COVID-19 pandemic: HAS recommendations.
: Focus on how to organize discharge for jaundice and the prevention of severe hyperbilirubinemia.
| The jaundice risk assessment must be integrated into the reasoning leading up to the decision for discharge from the maternity unit. |
| For each child, compilation of a jaundice profile based on the normogram [ |
| Jaundice follow-up procedures should: be effective within 24 h of early discharge from the maternity unit. enable quantification of jaundice. enable physical evaluation of the child (weighing) and breastfeeding (observation of a feed). identify a possible return route (if necessary) to a care facility. |
| It is recommended that jaundice data be recorded in the child's health record, or that this information (risk factors, profile outcome, diagnosis and test results) be mentioned on the immediate post-partum liaison sheet for the professional(s) providing follow-up [ |
| In practice, if the midwife does not have a bilirubinometer, she should be able to arrange for a bilirubin test at the maternity ward. As part of early discharge during the COVID-19 pandemic, it is important to monitor clinical signs and arrange for bilirubin monitoring at a private practice or at the hospital if necessary. |
| In the event of jaundice, phototherapy must be organized via secure channels in the maternity unit where the woman gave birth. |